Prostate-specific Membrane Antigen-targeted Ligand Positron Emission Tomography/Computed Tomography and Immunohistochemical Findings in a Patient With Synchronous Metastatic Penile and Prostate Cancer

被引：9
作者：
Froehner, Michael [1 ]
Kuithan, Friederike
Zoephel, Klaus
Heberling, Ulrike
Laniado, Michael
Wirth, Manfred P.
机构：
[1] Tech Univ Dresden, Dept Urol, Univ Hosp Carl Gustav Carus, Fetscherstr 74, D-01307 Dresden, Germany
来源：
UROLOGY | 2017年 / 101卷
关键词：
EXPRESSION; CARCINOMA;
D O I：
10.1016/j.urology.2016.11.040
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A 68-year-old man presented with synchronous metastatic penile and prostate cancer. 68Ga-labeled prostate-specific membrane antigen-targeted ligand positron emission tomography/computed tomography (PSMA-PET/CT) revealed tracer uptake in inguinal, pelvic, and retroperitoneal metastases. Lymph node biopsies and immunohistochemical staining revealed that both cancers involved the lymph nodes and expressed PSMA. In the deposits of penile squamous cell carcinoma, PSMA expression was seen in tumor vessels and may explain the PSMA-PET/CT positivity of inguinal nodes involved in squamous cell carcinoma. The interpretation of imaging in synchronous tumors should take this fact into consideration. (C) 2016 Elsevier Inc.
引用
收藏
页码：E5 / E6
页数：2
相关论文
共 50 条
  • [21] 68Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends
    Udovicich, Cristian
    Perera, Marlon
    Hofman, Michael S.
    Siva, Shankar
    Del Rio, Andres
    Murphy, Declan G.
    Lawrentschuk, Nathan
    PROSTATE INTERNATIONAL, 2017, 5 (04) : 125 - 129
  • [22] Using prostate-specific membrane antigen positron-emission tomography to guide prostate biopsies and stage men at high-risk of prostate cancer
    Bodar, Yves J. L.
    Boeve, Liselotte M. S.
    van Leeuwen, Pim J.
    Baars, Phillippe C.
    Nieuwenhuijzen, Jakko A.
    van Haarst, Ernst P.
    Oddens, Jorg R.
    Donswijk, Maarten L.
    van Riel, Luigi A. M. J. G.
    Scheltema, Matthijs J.
    Meijer, Dennie
    Hendrikse, N. Harry
    Oprea-Lager, Daniela E.
    Vis, Andre N.
    BJU INTERNATIONAL, 2023, 132 (06) : 705 - 712
  • [23] Canadian Urological Association best practice report: Prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) and PET/magnetic resonance (MR) in prostate cancer
    Shayegan, Bobby
    Zukotynski, Katherine
    Benard, Francois
    Menard, Cynthia
    Kuk, Joda
    Sistani, Golmehr
    Bauman, Glenn
    Veit-Haibach, Patrick
    Metser, Ur
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2021, 15 (06): : 162 - 172
  • [24] Application of 18F Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Monitoring Gastric Metastasis and Cancer Thrombi from Renal Cell Carcinoma
    Xiong, Min
    Zhang, Weiguang
    Zhou, Chao
    Bao, Junjie
    Zang, Shengbing
    Lin, Xiaoping
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [25] A Review of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC)
    Ahn, Thomas
    Roberts, Matthew J.
    Abduljabar, Aous
    Joshi, Andre
    Perera, Marlon
    Rhee, Handoo
    Wood, Simon
    Vela, Ian
    MOLECULAR IMAGING AND BIOLOGY, 2019, 21 (05) : 799 - 807
  • [26] Prostate-Specific Membrane Antigen-Targeted Theranostics: Past, Present, and Future Approaches
    Hawkey, Nathan M.
    Sartor, Alton O.
    Morris, Michael J.
    Armstrong, Andrew J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (04) : 227 - 238
  • [27] A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agent
    Nedrow-Byers, Jessie R.
    Jabbes, Mohamed
    Jewett, Cayla
    Ganguly, Tanushree
    He, Haiyang
    Liu, Tiancheng
    Benny, Paul
    Bryan, Jeffrey N.
    Berkman, Clifford E.
    PROSTATE, 2012, 72 (08) : 904 - 912
  • [28] Prostate specific membrane antigen positron emission tomography/computed tomography and staging high risk prostate cancer: a non-systematic review of high clinical impact literature
    Morigi, Joshua J.
    Anderson, Jack
    De Nunzio, Cosimo
    Fanti, Stefano
    MINERVA UROLOGY AND NEPHROLOGY, 2021, 73 (01): : 32 - 41
  • [29] Fluorine-18 labelled prostate-specific membrane antigen (PSMA)-1007 positron-emission tomography-computed tomography: normal patterns, pearls, and pitfalls
    Foley, R. W.
    Redman, S. L.
    Graham, R. N.
    Loughborough, W. W.
    Little, D.
    CLINICAL RADIOLOGY, 2020, 75 (12) : 903 - 913
  • [30] Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption
    Liu, Tiancheng
    Wu, Lisa Y.
    Berkman, Clifford E.
    CANCER LETTERS, 2010, 296 (01) : 106 - 112
12345